

(Alliance News) - GSK PLC on Friday said the European Commission has approved Nucala, or mepolizumab, as add-on therapy for adults with chronic obstru...


(Alliance News) - UK house prices rise more sharply than expected, GSK wins approval for Nucala to treat chronic obstructive pulmonary disease in the ...


(Sharecast News) - Drugmaker GSK said on Friday that the European Commission has approved Nucala (mepolizumab) as an add‑on maintenance treatmen...


WASHINGTON, Feb 5 (Reuters) - U.S. President Donald Trump plans to unveil TrumpRx.gov on Thursday, a website meant to offer consumers access to disco...


(Alliance News) - Stocks in London slumped on Thursday, tracking US and European counterparts, as investors weighed rate calls in Europe and the UK an...


(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Friday:


Feb 4 (Reuters) - Investors were assessing on Wednesday whether a selloff in global software stocks this week had gone too far, as they weighed if bus...


Feb 4 (Reuters) - European shares closed at a record high on Wednesday, though the gains were modest as a telecom sector rally and strength in consum...